Navigation Links
EpiCept Corporation to Present New NP-1 Data at American Pain,Society Meeting

Supports Local Mechanism of Action of NP-1 in Neuropathic Pain

TARRYTOWN, N.Y., May 03, 2007 /PRNewswire-FirstCall/ -- EpiCept Corporation announced today that it will present new data for EpiCept(TM) NP-1 on Thursday, May 3, 2007 at the 26th Annual Scientific Meeting of the American Pain Society in Washington D.C. EpiCept NP-1 is a patented topical cream formulation of two FDA-approved drugs, 4% amitriptyline and 2% ketamine. NP-1 is a product candidate intended for use in the management of pain resulting from various peripheral neuropathies. Two studies will be presented in poster format by Dennis Everton, RPh., Director of Clinical Development.

Results from a new human pharmacokinetic study of NP-1 designed to assess the pharmacokinetic parameters as well as its safety and tolerability will be presented. The highest observed level of amitriptyline at any time point was 5.91 ng/mL. The highest observed level of ketamine at any time point was 10.7 ng/mL. These levels are far below any known systemic efficacy level and even further below any known systemic level associated with adverse reactions. The study found that NP-1 was safe and well tolerated across all age groups studied. The low systemic levels of amitriptyline and ketamine indicated a local mechanism of action rather than a systemic one. NP-1 is intended as additive therapy in neuropathic pain. This study confirms the independent topical mechanism of NP-1.

Findings will also be presented from a previously disclosed multicenter, double-blind, randomized, placebo controlled Phase II study of NP-1 in treating post-herpetic neuralgia (PHN) in 118 patients. The study was designed to evaluate the analgesic properties of two different strengths of NP-1 compared with placebo in the treatment of PHN. The study met its primary endpoint of an improvement in pain intensity for the high dose strength vs. placebo from baseline to day 21 (p=0.026). Add
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mode of Action of EpiCept-Licensed Cancer Compound Profiled at AACR
2. Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. Millipore Corporation Announces New ReNcell Data from Collaboration with ReNeuron
4. NanoBio Corporation Announces Positive Phase 1 Clinical Results for Topical Treatment for Onychomycosis
5. Alba Therapeutics Corporation Reports Preliminary Phase IIa Clinical Trial Results for AT-1001 for the Treatment of Celiac Disease
6. The Past, Present and Future of HLA Typing
7. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology

Post Your Comments:
(Date:11/25/2009)... NEW YORK, Nov. 25 Reportlinker.co...vailable in its catalogue: ,, United States De... ,, http://www.reportlinker.com/p0158733/Unit...asts-to-2015.html ,, United States Dental Devi...ummary ,, This report is an essential source f...
(Date:11/25/2009)...CITY, Calif., Nov. 25 Ab...mpany manufacturing point-of-care blood analysis s...man and chief executive officer, will present at t...e on Wednesday, December 2, 2009 at 2:00 p.m. ET. ... Hotel in New York City. ,, About Abaxis ,...
(Date:11/25/2009)... WALTHAM, Mass., Nov. 25 According...thority on medical technology market intelligence,...on devices will continue to see rapid growth over ...owdown. MRG,s US Markets for Trauma Devices 201...y dynamic over the next five years, with competito...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 1Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 2Rochester Medical Launches StrataSI 28TM 29 26 StrataNF 28TM 29 Next Generation Foley Catheters 56132 3Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 1Regado Biosciences to Present at the Rodman 26 Renshaw Global Investment Conference on September 10 2009 13829 2Alltech Breaks Through 3A Named Top Green Company by Inc Magazine 13825 1Alltech Breaks Through 3A Named Top Green Company by Inc Magazine 13825 2
...IETTA, Ga., June 17 Solvay Pharmaceuticals, Inc.,...dy data conducted by the,Los Angeles Biomedical Re...wed that initial treatment response of hypogonadal...ad similar effects on subjects, regardless of,weig...were presented today,at the 2008 Endocrine Society...
...HLEHEM, Pa., June 17 Saladax Biomedical, a compan...nitoring, today announced,CE mark registration in ...Chemotherapy Management (PCM(R)) assay on the Olym...n oncologists who prescribe 5-fluorouracil,(5-FU) ...on (e.g., FOLFOX,and FOLFIRI) for colorectal, stom...
Other Medicine Technology:New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 2New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 3New Subset Analysis of AndroGel(R) Data Highlights Efficacy - Regardless of BMI 4Saladax Biomedical's 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU 2Saladax Biomedical's 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU 3
(Date:11/29/2009)... Moravia,s Nanjing-based Service Delivery Cente... Brno, Czech Republic (PRWEB...lution provider, is pleased to announce its partic...to be held in Nanjing, China, on November 30, 2009...ased companies that have established and grown a p...
(Date:11/29/2009)...w connections begin to form between brain cells al...rding to a study published this week in Nature . ..., Santa Cruz, the study involved detailed observat...the brain during motor learning. , The researche...ugh a slot to get a seed. They observed rapid grow...
(Date:11/29/2009)...he sleep disorder boosts urine production, experts...s) -- People who wake up during the night to urina...lem. Sleep apnea, a breathing-related sleep disord...that nighttime urination, or nocturia, is comparab...ep apnea, a disorder in which soft tissue in the t...
(Date:11/28/2009)... Nov. 28 Get ready for advanced...inical routine when Siemens introduces syng...Annual Meeting of the Radiological Society of Nort... McCormick Place (Booth #825, East Building/Lakesi...a , Siemens, new imaging software for multimoda...
(Date:11/27/2009)...Mass., Nov. 27 GSI Group...ier of precision technology products and semicondu...ng of the Company,s shareholders has been schedule...on of the meeting will be announced in due course....requisition notice from Stephen Bershad, a holder ...
Breaking Medicine News(10 mins):Health News:Moravia Worldwide to Participate in the 5th EU-China Business Summit 2009 in Nanjing China 2Health News:Study shows new brain connections form rapidly during motor learning 2Health News:Study shows new brain connections form rapidly during motor learning 3Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:GSI Group Calls Shareholders Meeting 2
...stCall/ -- Lotus,Pharmaceuticals, Inc. (OTC Bullet...maceutical company in the People,s Republic of Chi... conference call at 10:00,a.m. Eastern Time on Mon...Pharmaceuticals, will be Mr. Adam Wasserman, Chief...
...ndard across all health care,management programs, ...s approved comprehensive revisions to nine of the,...n programs. The changes,include additions to URAC,...r organizational quality that are a,part of all of...
... Relational Uncertainty refers to people,s lack o...involvement. A new study in the journal Personal R...cy and relational uncertainty and found that fluct... University and Jennifer A. Theiss of Rutgers Univ...
...in damage, even in the absence of dementia , ...al frailty among the elderly may be linked to earl...t patients develop dementia, new research reveals....lzheimer,s -- one that appears before mental decli...
...un Run to Help Benefit Canine,Cancer Research Whil...3 Los Angeles area dogs and dog,guardians are com... for the,Cure(TM), a five kilometer fun run and wa...nd awareness for canine,cancer research. All proce...
...er $7 Million for the Jimmy Fund, BELLINGHAM, Mas...gland Monday raised just over $800,000 for the Dan...ceeds generated from the 11th Annual,Dunkin, Donut...ternational Country Club in Bolton, Mass., is,cons...
Other Medicine News:Health News:Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results 2Health News:URAC Releases Revised Standards For Nine Health Care Management Accreditation Programs 2Health News:URAC Releases Revised Standards For Nine Health Care Management Accreditation Programs 3Health News:URAC Releases Revised Standards For Nine Health Care Management Accreditation Programs 4Health News:Physical Frailty Could Predict Alzheimer's Disease 2Health News:Physical Frailty Could Predict Alzheimer's Disease 3Health News:LA's Dogs Unite to 'Bark for the Cure' 2Health News:LA's Dogs Unite to 'Bark for the Cure' 3Health News:Dunkin' Donuts Event Raises $800,000 for Cancer Research in One Day 2
Dale First Rib Rongeur
De Vilbiss Cranial Rongeur
...e system features an advanced design that accommod...rinica system gives surgeons the flexibility to ea.... Flexibility is built-in to every aspect of the T... Secure-Twist anti-migration system to the screw o...
Atlantis Anterior Cervical Plate System
Medicine Products: